Top

Open Access 07-12-2024 | Hypoglycemia | Original Article

Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study

Authors: Giovanni Fanni, Sofia Kvernby, Sadiq Radhi, Argyri Mathioudaki, Magnus Sundbom, Sven Haller, Erika Roman, Johan Wikström, Mark Lubberink, Jan W. Eriksson

Published in: Endocrine

Abstract

Purpose

We aimed to characterize the RYGB-induced changes in the dynamics of brain glucose uptake. We addressed heterogeneity between brain regions during experimental normo- and hypoglycemia and explored associations with anthropometric and metabolic outcomes of RYGB.

Methods

Analyses of regional brain glucose uptake were performed on 9 individuals with obesity and no diabetes, investigated with combined brain ¹⁸F-FDG-PET and fMRI during hyperinsulinemic normo- and hypoglycemic clamp, one month before and four months after RYGB. FDG clearance, reflecting glucose uptake rate, was assessed in 38 brain regions, covering all cortical areas and subcortical nuclei, during hyperinsulinemic normo- and hypoglycemia. Correlation analyses were performed to identify associations with other outcomes of RYGB.

Results

FDG uptake rate during hypoglycemia was higher than during normoglycemia in all brain regions, both before and after RYGB. Moreover, in most regions and especially in cortical areas involved in inhibitory behavioral control, FDG uptake rate tended to be reduced after surgery during normoglycemia but elevated during hypoglycemia. However, these post-surgical changes in FDG uptake rate were opposite in the hypothalamus. Thus, the hypo-to-normoglycemia FDG clearance ratio tended to increase in all brain regions following RYGB, but not in the amygdala and the hypothalamus. Changes in regional FDG uptake rate after RYGB during normoglycemia were associated with weight loss and improved systemic insulin sensitivity.

Conclusion

Using dynamic FDG-PET, we show region-specific patterns of changes in glucose utilization following RYGB. In the hypothalamus, glucose uptake during normoglycemia tended to rise after RYGB while it was reduced in cortical regions involved in behavioral control. Following RYGB, the hypothalamus and amygdala, in contrast to other regions, displayed trends of reduced glucose uptake during hypoglycemia. These pilot results highlight the brain effects of RYGB and suggest behavioral and neuroendocrine adaptations which contribute to its antidiabetic effects.

Available only for authorised users

P.R. Schauer, G. Mingrone, S. Ikramuddin, B. Wolfe, Clinical outcomes of metabolic surgery: Efficacy of glycemic control, weight loss, and remission of diabetes. Diab. Care 39, 902–911 (2016). https://doi.org/10.2337/DC16-0382CrossRef

I. Cornejo-Pareja, M. Clemente-Postigo, F.J. Tinahones, Metabolic and endocrine consequences of bariatric surgery. Front Endocrinol. (Lausanne) 10, 626 (2019). https://doi.org/10.3389/fendo.2019.00626CrossRefPubMed

J. Berggren, A. Lindqvist, J. Hedenbro, L. Groop, N. Wierup, Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal. Surg. Obes. Relat. Dis. 13, 234–242 (2017). https://doi.org/10.1016/J.SOARD.2016.09.017CrossRefPubMed

L.E. Sewaybricker, E.A. Schur, Is bariatric surgery brain surgery? Diabetes 70, 1244–1246 (2021). https://doi.org/10.2337/dbi21-0022CrossRefPubMedPubMedCentral

E. Rebelos, H. Immonen, M. Bucci, J.C. Hannukainen, L. Nummenmaa, M.J. Honka, M. Soinio, P. Salminen, E. Ferrannini, P. Iozzo, P. Nuutila, Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow-up. Diab. Obes. Metab. 21, 218–226 (2019). https://doi.org/10.1111/dom.13501CrossRef

N. Abrahamsson, B.E. Engström, M. Sundbom, F.A. Karlsson, Hypoglycemia in everyday life after gastric bypass and duodenal switch. Eur. J. Endocrinol. 173, 91–100 (2015). https://doi.org/10.1530/EJE-14-0821CrossRefPubMed

A.S. Al-Alsheikh, S. Alabdulkader, A.D. Miras, A.P. Goldstone, Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies. Obes. Rev. 24, e13620 (2023). https://doi.org/10.1111/OBR.13620CrossRefPubMedPubMedCentral

K.E. Almby, M.H. Lundqvist, N. Abrahamsson, S. Kvernby, M. Fahlström, M.J. Pereira, M. Gingnell, F.A. Karlsson, G. Fanni, M. Sundbom, U. Wiklund, S. Haller, M. Lubberink, J. Wikström, J.W. Eriksson, Effects of Gastric Bypass Surgery on the Brain: Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity, and Cognitive Function During Normo- and Hypoglycemia. Diabetes 70, 1265–1277 (2021). https://doi.org/10.2337/db20-1172CrossRefPubMedPubMedCentral

G. Fanni, C. Kagios, E. Roman, M. Sundbom, J. Wikström, S. Haller, J.W. Eriksson, Effects of gastric bypass surgery on brain connectivity responses to hypoglycemia. Endocrine 79, 304–312 (2022). https://doi.org/10.1007/s12020-022-03253-yCrossRefPubMedPubMedCentral

10.

A.J. López-Gambero, F. Martínez, K. Salazar, M. Cifuentes, F. Nualart, Brain glucose-sensing mechanism and energy homeostasis, https://pubmed.ncbi.nlm.nih.gov/29796992/, (2019). https://doi.org/10.1007/s12035-018-1099-4

11.

J.D. Deem, K. Muta, J.M. Scarlett, G.J. Morton, M.W. Schwartz, How should we think about the role of the brain in glucose homeostasis and diabetes? Diabetes 66, 1758–1765 (2017). https://doi.org/10.2337/dbi16-0067CrossRefPubMedPubMedCentral

12.

K. Coveleskie, A. Gupta, L.A. Kilpatrick, E.D. Mayer, C. Ashe-Mcnalley, J. Stains, J.S. Labus, E.A. Mayer, Altered functional connectivity within the central reward network in overweight and obese women. Nutr. Diab. 5, e148 (2015). https://doi.org/10.1038/nutd.2014.45. 2015 5:1CrossRef

13.

G.J. Morton, T.H. Meek, M.W. Schwartz, Neurobiology of food intake in health and disease. Nat. Rev. Neurosci. 15, 367–378 (2014). https://doi.org/10.1038/nrn3745CrossRefPubMedPubMedCentral

14.

I. Lundgaard, B. Li, L. Xie, H. Kang, S. Sanggaard, J.D.R. Haswell, W. Sun, S. Goldman, S. Blekot, M. Nielsen, T. Takano, R. Deane, M. Nedergaard, Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. Nat. Commun. 6, 6807 (2015). https://doi.org/10.1038/NCOMMS7807CrossRefPubMed

15.

E. Rebelos, M. Bucci, T. Karjalainen, V. Oikonen, A. Bertoldo, J.C. Hannukainen, K.A. Virtanen, A. Latva-Rasku, J. Hirvonen, I. Heinonen, R. Parkkola, M. Laakso, E. Ferrannini, P. Iozzo, L. Nummenmaa, P. Nuutila, Insulin resistance is associated with enhanced brain glucose uptake during euglycemic hyperinsulinemia: A large-scale PET cohort. Diab. Care 44, 788–794 (2021). https://doi.org/10.2337/dc20-1549CrossRef

16.

G.J. Boersma, E. Johansson, M.J. Pereira, K. Heurling, S. Skrtic, J. Lau, P. Katsogiannos, G. Panagiotou, M. Lubberink, J. Kullberg, H. Ahlström, J.W. Eriksson, Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: A combined PET/MR study. Horm. Metab. Res. 50, e10 (2018). https://doi.org/10.1055/a-0831-3620CrossRefPubMed

17.

J. Hirvonen, K.A. Virtanen, L. Nummenmaa, J.C. Hannukainen, M.J. Honka, M. Bucci, S.V. Nesterov, R. Parkkola, J. Rinne, P. Iozzo, P. Nuutila, Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 60, 443–447 (2011). https://doi.org/10.2337/db10-0940CrossRefPubMedPubMedCentral

18.

J.J. Tuulari, H.K. Karlsson, J. Hirvonen, J.C. Hannukainen, M. Bucci, M. Helmiö, J. Ovaska, M. Soinio, P. Salminen, N. Savisto, L. Nummenmaa, P. Nuutila, Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes 62, 2747–2751 (2013). https://doi.org/10.2337/db12-1460CrossRefPubMedPubMedCentral

19.

A. Dardano, G. Aghakhanyan, C. Moretto, A. Ciccarone, R. Bellini, V. Sancho Bornez, G. Ceccarini, F. Santini, D. Volterrani, S. Del Prato, G. Daniele, Brain effect of bariatric surgery in people with obesity. Int J. Obes. 46, 1671–1677 (2022). https://doi.org/10.1038/s41366-022-01162-8CrossRef

20.

Rebelos, E., Mari, A., Bucci, M., Honka, M.J., Hannukainen, J.C., Virtanen, K.A., Hirvonen, J., Nummenmaa, L., Heni, M., Iozzo, P., Ferrannini, E., Nuutila, P.: Brain substrate metabolism and ß-cell function in humans: A positron emission tomography study. Endocrinol Diabetes Metab. 3, (2020). https://doi.org/10.1002/edm2.136.

21.

B.L. Viglianti, K.K. Wong, S.M. Wimer, A. Parameswaran, B. Nan, C. Ky, D.M. Townsend, D. Rubello, K.A. Frey, M.D. Gross, Effect of hyperglycemia on brain and liver 18 F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging. Biomed. Pharmacother. 88, 1038–1045 (2017). https://doi.org/10.1016/j.biopha.2017.01.166CrossRefPubMedPubMedCentral

22.

K.F. Hunt, J.T. Dunn, C.W. le Roux, L.J. Reed, P.K. Marsden, A.G. Patel, S.A. Amiel, Differences in regional brain responses to food ingestion after Roux-en-Y gastric bypass and the role of gut peptides: A neuroimaging study. Diab Care 39, 1787–1795 (2016). https://doi.org/10.2337/dc15-2721CrossRef

23.

A. Gastaldelli, Measuring and estimating insulin resistance in clinical and research settings. Obesity. 30, 1549–1563 (2022). https://doi.org/10.1002/OBY.23503CrossRefPubMed

24.

C. Svarer, K. Madsen, S.G. Hasselbalch, L.H. Pinborg, S. Haugbøl, V.G. Frøkjær, S. Holm, O.B. Paulson, G.M. Knudsen, MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24, 969–979 (2005). https://doi.org/10.1016/J.NEUROIMAGE.2004.10.017CrossRefPubMed

25.

L.V. Hedges, Distribution theory for glass’s estimator of effect size and related estimators. J. Educ. Stat. 6, 107 (1981). https://doi.org/10.2307/1164588CrossRef

26.

A.K. Rehni, K.R. Dave, Impact of hypoglycemia on brain metabolism during diabetes. Mol. Neurobiol. 55, 9075–9088 (2018). https://doi.org/10.1007/S12035-018-1044-6. 2018 55:12CrossRefPubMedPubMedCentral

27.

E.R. Zimmer, M.J. Parent, D.G. Souza, A. Leuzy, C. Lecrux, H.I. Kim, S. Gauthier, L. Pellerin, E. Hamel, P. Rosa-Neto, [18F]FDG PET signal is driven by astroglial glutamate transport. Nat. Neurosci. 20, 393–395 (2017). https://doi.org/10.1038/nn.4492CrossRefPubMedPubMedCentral

28.

A. Jais, J.C. Brüning, Hypothalamic inflammation in obesity and metabolic disease. J. Clin. Invest 127, 24–32 (2017). https://doi.org/10.1172/JCI88878CrossRefPubMedPubMedCentral

29.

L. Sonnefeld, N. Rohmann, C. Geisler, M. Laudes, Is human obesity an inflammatory disease of the hypothalamus? Eur. J. Endocrinol. 188, R37–R45 (2023). https://doi.org/10.1093/EJENDO/LVAD030CrossRefPubMed

30.

O. Le Thuc, K. Stobbe, C. Cansell, J.L. Nahon, N. Blondeau, C. Rovère, Hypothalamic inflammation and energy balance disruptions: Spotlight on chemokines. Front Endocrinol. (Lausanne) 8, 197 (2017). https://doi.org/10.3389/FENDO.2017.00197/BIBTEXCrossRefPubMed

31.

N. Abrahamsson, J.L. Börjesson, M. Sundbom, U. Wiklund, F.A. Karlsson, J.W. Eriksson, Gastric bypass reduces symptoms and hormonal responses in hypoglycemia. Diabetes 65, 2667–2675 (2016). https://doi.org/10.2337/db16-0341CrossRefPubMed

32.

G. Sambuceti, V. Cossu, M. Bauckneht, S. Morbelli, A.M. Orengo, S. Carta, S. Ravera, S. Bruno, C. Marini, 18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at? Eur. J. Nucl. Med Mol. Imaging 48, 1278–1286 (2021). https://doi.org/10.1007/S00259-021-05368-2/FIGURES/2CrossRefPubMed

33.

S. Suda, M. Shinohara, M. Miyaoka, G. Lucignani, C. Kennedy, L. Sokoloff, The lumped constant of the deoxyglucose method in hypoglycemia: Effects of moderate hypoglycemia on local cerebral glucose utilization in the rat. J. Cereb. Blood Flow. Metab. 10, 499–509 (1990). https://doi.org/10.1038/jcbfm.1990.92CrossRefPubMed

Title: Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study
Authors: Giovanni Fanni
Sofia Kvernby
Sadiq Radhi
Argyri Mathioudaki
Magnus Sundbom
Sven Haller
Erika Roman
Johan Wikström
Mark Lubberink
Jan W. Eriksson
Publication date: 07-12-2024
Publisher: Springer US
Keyword: Hypoglycemia
Published in: Endocrine
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-024-04127-1

Elevate your expertise in aplastic anemia (Link opens in a new window)

Aplastic Anemia
Independent Medical Education

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases.

Supported by:

Pfizer

Developed by: Springer Healthcare IME

Learn more

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now